![Eric Jean Marie Leire](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Jean Marie Leire
Fondateur chez
GENFLOW BIOSCIENCES PLC
Fortune : 4 M $ au 30/06/2026
Profil
Eric Jean Marie Leire is the founder and currently holds the position of Chief Executive Officer & Executive Director at Genflow Biosciences Plc, which was founded in 2020.
He is also currently the Chief Executive Officer & Director at Renovaro Biosciences Denmark ApS since 2011.
Additionally, he holds the position of Director at Novicol International Holding, Inc., Immunethep SA, OSE Immunotherapeutics SA, Inhatarget Therapeutics, Bsim Therapeutics Ltd., PHAXIAM Therapeutics SA, and Partner at Biofund Venture Capital.
In his former positions, Dr. Leire served as President & Chief Executive Officer at APT Therapeutics, Inc. from 2002 to 2005.
He was also the Chief Executive Officer at Cantex Pharmaceuticals, Inc. and Renovaro, Inc. He held the position of Chief Executive Officer & Director at DKTI A and Dandrit Corp.
Pte Ltd. He worked as a Division Director at Pfizer Inc. and Schering-Plough Corp.
and served as a Non-Executive Director at Genizon Biosciences, Inc. He was the Director, Chief Executive & Financial Officer at Renovaro, Inc. from 2014 to 2017.
He also held positions at Biohemp International, Inc., FIT Biotech Oy, Pharmacia Corp., Egalet Ltd., and Medwell Capital Corp.Dr. Leire's education includes an MBA from École des Hautes Études Commerciales de Paris, a doctorate from the University of Grenoble, an MBA from Institut Supérieur des Affaires, and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENFLOW BIOSCIENCES PLC 22,34% | 27/03/2025 | 126 514 999 ( 22,34% ) | 4 M $ | 30/06/2026 |
Postes actifs de Eric Jean Marie Leire
| Sociétés | Poste | Début |
|---|---|---|
| GENFLOW BIOSCIENCES PLC | Fondateur | - |
| OSE IMMUNOTHERAPEUTICS | Directeur/Membre du Conseil | 22/06/2023 |
| PHAXIAM THERAPEUTICS S.A. | Directeur/Membre du Conseil | 23/06/2023 |
Immunethep SA
 Immunethep SA BiotechnologyHealth Technology Develops biological products | Directeur/Membre du Conseil | 01/01/2018 |
Bsim Therapeutics Ltd. | Directeur/Membre du Conseil | 01/05/2019 |
Inhatarget Therapeutics
 Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Develops drugs for cancer and chronic diseases | Directeur/Membre du Conseil | 01/08/2020 |
Novicol International Holding, Inc. | Directeur/Membre du Conseil | - |
Renovaro Biosciences Denmark ApS
 Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines | Directeur Général | 01/04/2011 |
Anciens postes connus de Eric Jean Marie Leire
| Sociétés | Poste | Fin |
|---|---|---|
| LUNAI BIOWORKS INC. | Directeur Général | 07/01/2019 |
| ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Eric Jean Marie Leire
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
27
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 27 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Medwell Capital Corp.
 Medwell Capital Corp. Investment ManagersFinance Operates as a investment and healthcare advisory firm | Finance |
APT Therapeutics, Inc.
 APT Therapeutics, Inc. Medical SpecialtiesHealth Technology Manufactures hospital equipment | Health Technology |
Genizon Biosciences, Inc.
 Genizon Biosciences, Inc. BiotechnologyHealth Technology Provides drug development services | Health Technology |
Cantex Pharmaceuticals, Inc.
 Cantex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops heparin to ameliorate cardiac ischemia-reperfusion injuries | Health Technology |
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
Biohemp International, Inc.
 Biohemp International, Inc. Pharmaceuticals: MajorHealth Technology Develops insomnia pharmaceuticals | Health Technology |
FIT Biotech Oy
 FIT Biotech Oy BiotechnologyHealth Technology Develops vaccines and DNA delivery technology | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Grenoble
 University of Grenoble Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institut Supérieur des Affaires
 Institut Supérieur des Affaires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DKTI A/S
 DKTI A/S Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Miscellaneous |
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Specializes in nano technologies for pharmaceutical purposes | Health Technology |
Renovaro Biosciences Denmark ApS
Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines | Commercial Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dandrit Corp. Pte Ltd. | |
Novicol International Holding, Inc. | |
Immunethep SA
Immunethep SA BiotechnologyHealth Technology Develops biological products | Health Technology |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Harvard Aids Initiative
 Harvard Aids Initiative Miscellaneous Commercial ServicesCommercial Services The Harvard AIDS Initiative operates within the Harvard T.H. Chan School of Public Health, focusing on interdisciplinary research, education, and community engagement in public health. The private company is based in Boston, MA. The school includes the Department of Immunology and Infectious Diseases, which conducts research on infectious diseases such as HIV/AIDS, tuberculosis, malaria, and emerging pathogens, integrating laboratory and field studies to develop diagnostics, vaccines, and treatments. The initiative emphasizes support for marginalized populations and fosters diversity and inclusion. Harvard Chan offers a variety of degree programs and specialized learning opportunities led by Harvard faculty, and supports an international student community with resources for academic, professional, and personal development. | Commercial Services |
Inhatarget Therapeutics
Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Develops drugs for cancer and chronic diseases | Health Technology |
Genflow Biosciences Plc
 Genflow Biosciences Plc BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Bsim Therapeutics Ltd. | |
PHAXIAM Therapeutics SA
 PHAXIAM Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops red blood cell-based therapeutics for severe forms of cancer & orphan diseases | Health Technology |
